118 related articles for article (PubMed ID: 21696923)
1. Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model.
Hahn M; Chintoh A; Giacca A; Xu L; Lam L; Mann S; Fletcher P; Guenette M; Cohn T; Wolever T; Arenovich T; Remington G
Schizophr Res; 2011 Sep; 131(1-3):90-5. PubMed ID: 21696923
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: an animal model.
Guenette MD; Giacca A; Hahn M; Teo C; Lam L; Chintoh A; Arenovich T; Remington G
Schizophr Res; 2013 May; 146(1-3):162-9. PubMed ID: 23499243
[TBL] [Abstract][Full Text] [Related]
3. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
4. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance following continuous, chronic olanzapine treatment: an animal model.
Chintoh AF; Mann SW; Lam TK; Giacca A; Remington G
Schizophr Res; 2008 Sep; 104(1-3):23-30. PubMed ID: 18675538
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats.
Murashita M; Kusumi I; Hosoda H; Kangawa K; Koyama T
Psychoneuroendocrinology; 2007 Aug; 32(7):777-84. PubMed ID: 17629416
[TBL] [Abstract][Full Text] [Related]
7. How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.
Starrenburg FC; Bogers JP
Eur Psychiatry; 2009 Apr; 24(3):164-70. PubMed ID: 19285836
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics.
Gilles M; Wilke A; Kopf D; Nonell A; Lehnert H; Deuschle M
Psychosom Med; 2005; 67(5):748-51. PubMed ID: 16204433
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.
Hahn MK; Chintoh A; Remington G; Teo C; Mann S; Arenovich T; Fletcher P; Lam L; Nobrega J; Guenette M; Cohn T; Giacca A
Eur Neuropsychopharmacol; 2014 Mar; 24(3):448-58. PubMed ID: 24001874
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system.
Ikegami M; Ikeda H; Ohashi T; Kai M; Osada M; Kamei A; Kamei J
Neuroendocrinology; 2013; 98(3):224-32. PubMed ID: 24135197
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.
Houseknecht KL; Robertson AS; Zavadoski W; Gibbs EM; Johnson DE; Rollema H
Neuropsychopharmacology; 2007 Feb; 32(2):289-97. PubMed ID: 17035934
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia.
Johnson DE; Yamazaki H; Ward KM; Schmidt AW; Lebel WS; Treadway JL; Gibbs EM; Zawalich WS; Rollema H
Diabetes; 2005 May; 54(5):1552-8. PubMed ID: 15855345
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
Wadenberg ML; Hertel P; Fernholm R; Hygge Blakeman K; Ahlenius S; Svensson TH
J Neural Transm (Vienna); 2000; 107(10):1229-38. PubMed ID: 11129112
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats.
Kumar PT; Antony S; Nandhu MS; Sadanandan J; Naijil G; Paulose CS
J Nutr Biochem; 2011 May; 22(5):418-25. PubMed ID: 20655720
[TBL] [Abstract][Full Text] [Related]
17. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
Weston-Green K; Huang XF; Lian J; Deng C
Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration.
Chintoh AF; Mann SW; Lam L; Lam C; Cohn TA; Fletcher PJ; Nobrega JN; Giacca A; Remington G
J Clin Psychopharmacol; 2008 Oct; 28(5):494-9. PubMed ID: 18794643
[TBL] [Abstract][Full Text] [Related]
19. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
